Hypothalamic CaMKKβ mediates glucagon anorectic effect and its diet-induced resistance

OBJECTIVE: Glucagon receptor antagonists and humanized glucagon antibodies are currently studied as promising therapies for obesity and type II diabetes. Among its variety of actions, glucagon reduces food intake, but the molecular mechanisms mediating this effect as well as glucagon resistance are...

Descripción completa

Detalles Bibliográficos
Autores principales: Quiñones, Mar, Al-Massadi, Omar, Gallego, Rosalía, Fernø, Johan, Diéguez, Carlos, López, Miguel, Nogueiras, Ruben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731730/
https://www.ncbi.nlm.nih.gov/pubmed/26909312
http://dx.doi.org/10.1016/j.molmet.2015.09.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731730/
https://www.ncbi.nlm.nih.gov/pubmed/26909312
http://dx.doi.org/10.1016/j.molmet.2015.09.014

Ejemplares similares